RSS Cellerix

RSS Cellerixhttp://www.cellerix.atela.biz/index.phpGuillermo Sellers named VP Medical and Regulatory of Cellerixhttp://www.cellerix.atela.biz/index.php/Press-Room/Press-releases/Guillermo-Sellers-named-VP-Medical-and-Regulatory-of-Cellerix Cellerix has appointed Guillermo Sellers as the new Medical and Regulatory Vice President of its management team The Lilly Foundation and Cellerix present the book “Cell Therapy”http://www.cellerix.atela.biz/index.php/Press-Room/Press-releases/The-Lilly-Foundation-and-Cellerix-present-the-book-Cell-Therapy Cell Therapy is the first book in the world published about a field that is revolutionizing medical practice Cellerix registers the name Ontaril® for its medicine Cx401http://www.cellerix.atela.biz/index.php/Press-Room/Press-releases/Cellerix-registers-the-name-Ontaril-R-for-its-medicine-Cx401 Cellerix has registered the name Ontaril® for its medicine Cx401. Miguel Fenoy, the New Director of Clinical Operations at Cellerix http://www.cellerix.atela.biz/index.php/Press-Room/Press-releases/Miguel-Fenoy-the-New-Director-of-Clinical-Operations-at-Cellerix Cellerix has appointed Miguel Fenoy to its team as Director of Clinical Operations. Miguel Ángel Galve, new Legal Manager of Cellerix http://www.cellerix.atela.biz/index.php/Press-Room/Press-releases/Miguel-Angel-Galve-new-Legal-Manager-of-Cellerix Cellerix has incorporated Miguel Ángel Galve to their team as Legal Manager. Claudia Jiménez, the New Director of Business Development at Cellerixhttp://www.cellerix.atela.biz/index.php/Press-Room/Press-releases/Claudia-Jimenez-the-New-Director-of-Business-Development-at-Cellerix Cellerix has appointed Claudia Jimenez to its team as Director of Business Development. Cellerix appoints Jacques Theurillat as Member of its Board of Directorshttp://www.cellerix.atela.biz/index.php/Press-Room/Press-releases/Cellerix-appoints-Jacques-Theurillat-as-Member-of-its-Board-of-Directors Cellerix has appointed Jacques Theurillat as new member of its Board of Directors Cellerix grants Axcan rights to Cx401 in North Americahttp://www.cellerix.atela.biz/index.php/Press-Room/Press-releases/Cellerix-grants-Axcan-rights-to-Cx401-in-North-America Cellerix has entered into an exclusive license and development agreement with Axcan Pharma Inc. for the North American (United States, Canada and Mexico) rights to Cx401. Cellerix closes €27,2m financing round to bring product Cx401 to market http://www.cellerix.atela.biz/index.php/Press-Room/Press-releases/Cellerix-closes-27-2m-financing-round-to-bring-product-Cx401-to-market Cellerix closes a series B financing round with international venture capital companies and corporate funds from two of the largest pharmaceutical companies.